Photo source: Reuters
Johnson & Johnson beat their own expectations for quarterly earnings from Covid19 vaccines. They raised dividend payouts to shareholders on Tuesday and reported $100m in sales, and its use was paused by United States regulators last week.
The company already made it clear that the vaccine will be available on a not-for-profit basis until the end of the pandemic. The vaccine use was temporarily halted by US regulators as they examined reports of blood clots in six women. They noticed an identical pause in South Africa and resulted in a delay in roll-out in Europe. They are also handling worst cases of severe side effects in addition to those which led to the pause in the country.
J&J is aiming to deliver 100 million doses of the vaccine to the US. They are expecting it to be delivered before the end of May. More than 17 million of these doses have already been distributed as of Monday.
Data source: Reuters
Nigeria’s leading music figure and vocalist, Cobhams Asuquo, known for his singing and production said…
Following a mixed reaction from the South African community representatives, Khoi and San, the Cape…
Mitigating the process and service barriers in African rail transportation, the digital disruption has transformed…
Kais Saied, the Tunisian president has said in his speech that he will allow the…
You know the credibility of an ingredient when it’s plastered all over bottles and jars…
Cyclone Gombe that flooded large areas of central and northern Mozambique is consistently leading to…
This website uses cookies.